Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Neuroleptics and Cognition]

Alexander Brunnauer1, Elisabeth Geiger, Gerd Laux

  • 1Bezirksklinikum Gabersee, Fachkrankenhaus für Psychiatrie, Psychotherapie und Neurologie, Abteilung Neuropsychologie. Brunnauer.Alexander@gabersee.de

Psychiatrische Praxis
|September 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

Pharmacopsychiatry·2026
Same author

[Mental diseases and driving ability-An update].

Der Nervenarzt·2026
Same author

Case Report: Effect of medicinal cannabis on fitness to drive in a patient with Tourette Syndrome and ADHD.

Frontiers in psychiatry·2025
Same author

The impact of aerobic endurance training on cognitive performance in schizophrenic inpatients in a clinical routine setting.

European archives of psychiatry and clinical neuroscience·2024
Same author

The Effect of Nabiximols on Driving Ability in Adults with Chronic Tic Disorders: Results of a Substudy Analysis of the Double-Blind, Randomized, Placebo-Controlled CANNA-TICS Trial.

Cannabis and cannabinoid research·2024
Same author

Driving-related cognitive skills during antidepressant transcranial direct current stimulation: results in a subsample from the DepressionDC trial.

Frontiers in psychiatry·2023
Same journal

[Weight-related nutritional interventions for people with mental illness in psychiatric clinics in Germany].

Psychiatrische Praxis·2026
Same journal

[Interdisciplinary Collaboration between Social Service and Case Management in Child and Adolescent Psychiatry: A Qualitative Study of Barriers, Facilitators and the Family Caregiver Perspective].

Psychiatrische Praxis·2026
Same journal

[Work with People with Intellectual Disabilities and Challenging Behavior: Resources, Stressors, and Organizational Approaches].

Psychiatrische Praxis·2026
Same journal

[When IPS Coaching isn't always effective: Findings from the German IPS-ZIB Project].

Psychiatrische Praxis·2026
Same journal

[Borderline personality disorder as a severe mental illness: results of an empirical study].

Psychiatrische Praxis·2026
Same journal

[Firearm Suicides In Switzerland From 1969 To 2023].

Psychiatrische Praxis·2026
See all related articles

Atypical antipsychotics significantly improved cognitive function, particularly short-term memory and retention, in schizophrenic patients compared to conventional neuroleptics in routine clinical practice.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Schizophrenia is a complex mental disorder often associated with significant cognitive deficits.
  • Cognitive impairment in schizophrenia impacts daily functioning and treatment outcomes.
  • Evaluating the real-world effectiveness of different antipsychotic classes on cognition is crucial.

Purpose of the Study:

  • To assess the impact of atypical antipsychotics on various cognitive domains in patients with schizophrenia.
  • To compare the cognitive effects of atypical antipsychotics versus conventional neuroleptics under clinical routine conditions.

Main Methods:

  • A cohort of 78 patients diagnosed with schizophrenia was recruited.
  • Neuropsychological tests were administered to evaluate attention, short-term memory, working memory, learning, long-term memory (retention), and executive function.

Related Experiment Videos

  • Data analysis considered medication type, illness severity, and patient age.

    • Main Results:

    • Treatment with atypical antipsychotics demonstrated a statistically significant advantage in cognitive function compared to conventional neuroleptics.
    • A notable improvement was observed in short-term memory and long-term memory retention with atypical antipsychotics.
    • These benefits were evident even within the context of standard clinical care.

    Conclusions:

    • Atypical antipsychotics offer a cognitive benefit over conventional neuroleptics for patients with schizophrenia.
    • The findings support the use of atypical antipsychotics to address cognitive deficits in schizophrenia in routine clinical settings.
    • Further research could explore the specific mechanisms underlying these cognitive improvements.